Minar E - Search Results

1

p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.

Exner M, Alt E, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Minar E, Gmeiner B. Exner M, et al. Among authors: minar e. FEBS Lett. 2001 Feb 9;490(1-2):28-31. doi: 10.1016/s0014-5793(01)02131-7. FEBS Lett. 2001. PMID: 11172805 Free article.

2

Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients.

Ziegler S, Alt E, Brunner M, Speiser W, Minar E. Ziegler S, et al. Among authors: minar e. Ann Hematol. 2004 Feb;83(2):92-4. doi: 10.1007/s00277-003-0789-8. Epub 2003 Oct 10. Ann Hematol. 2004. PMID: 14551743

3

Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients.

Ziegler S, Maca T, Alt E, Speiser W, Schneider B, Minar E. Ziegler S, et al. Among authors: minar e. Platelets. 2002 Dec;13(8):493-7. doi: 10.1080/0953710021000057866. Platelets. 2002. PMID: 12487783

4

D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease.

Koppensteiner R, Speiser W, Minar E, Ahmadi R, Ehringer H. Koppensteiner R, et al. Among authors: minar e. Thromb Haemost. 1990 Oct 22;64(2):192-5. Thromb Haemost. 1990. PMID: 2125370

5

D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.

Speiser W, Mallek R, Koppensteiner R, Stümpflen A, Kapiotis S, Minar E, Ehringer H, Lechner K. Speiser W, et al. Among authors: minar e. Thromb Haemost. 1990 Oct 22;64(2):196-201. Thromb Haemost. 1990. PMID: 2125371

6

Results of a new rapid d-dimer assay (cardiac d-dimer) in the diagnosis of deep vein thrombosis.

Bucek RA, Quehenberger P, Feliks I, Handler S, Reiter M, Minar E. Bucek RA, et al. Among authors: minar e. Thromb Res. 2001 Jul 1;103(1):17-23. doi: 10.1016/s0049-3848(00)00367-4. Thromb Res. 2001. PMID: 11434942

7

Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty.

Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O. Exner M, et al. Among authors: minar e. J Endovasc Ther. 2001 Oct;8(5):433-40. doi: 10.1177/152660280100800501. J Endovasc Ther. 2001. PMID: 11718398

8

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S. Kyrle PA, et al. Among authors: minar e. N Engl J Med. 2000 Aug 17;343(7):457-62. doi: 10.1056/NEJM200008173430702. N Engl J Med. 2000. PMID: 10950667 Free article.

9

Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.

Schillinger M, Haumer M, Schlerka G, Mlekusch W, Exner M, Ahmadi R, Minar E. Schillinger M, et al. Among authors: minar e. J Endovasc Ther. 2001 Oct;8(5):477-83. doi: 10.1177/152660280100800509. J Endovasc Ther. 2001. PMID: 11718406

10

The risk of recurrent venous thromboembolism among patients with high factor IX levels.

Weltermann A, Eichinger S, Bialonczyk C, Minar E, Hirschl M, Quehenberger P, Schönauer V, Kyrle PA. Weltermann A, et al. Among authors: minar e. J Thromb Haemost. 2003 Jan;1(1):28-32. doi: 10.1046/j.1538-7836.2003.00038.x. J Thromb Haemost. 2003. PMID: 12871536 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters